TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$6.86
Tradestie Score
55
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+78.3%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTLA
Intellia Therapeutics, Inc
|
$15.25
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.31
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.12
|
$1.92B | - | 57 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$90.21
|
$1.92B | - | 54 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$74.04
|
$1.90B | 444.1 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$38.20
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.20
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.63
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.26
|
$1.78B | - | 62 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.28
|
$1.74B | - | 61 | Compare |
More TSHA Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry